SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-088680
Filing Date
2020-03-27
Accepted
2020-03-27 16:08:57
Documents
4
Period of Report
2020-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d818014d8k.htm 8-K 23832
2 EX-1.1 d818014dex11.htm EX-1.1 183137
3 EX-5.1 d818014dex51.htm EX-5.1 8144
4 GRAPHIC g818014g0327035436880.jpg GRAPHIC 2654
  Complete submission text file 0001193125-20-088680.txt   220253
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 20751859
SIC: 2834 Pharmaceutical Preparations